Cognito Therapeutics reported in Boston on 16 November that Spectris AD—goggles and headphones used one hour daily at home to drive gamma brain activity—did not improve cognition versus sham after one year in Alzheimer’s disease. CEO Christian Howell still plans an FDA filing next year, citing gains